Additionally, the values for tumor markers, including CYF211 and NSE, were higher in patients with the rs 21319877 T/C+C/C genotype in tumor tissue, and NSE was higher in patients with the rs 2131877 T/C+C/C genotype in blood. The gene discussed is ENO2; the disease is neoplasm.